Evidence map›Paper›PMID 34754030›Full record

ArticleScientific reports2021

Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort study.

Anna Graipe, Anders Ulvenstam, Anna-Lotta Irevall, Lars Söderström, Thomas Mooe

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna GraipeInstitution of Public Health and Clinical Medicine, Östersund, Umeå University, Umeå, Sweden. anna.graipe@regionjh.se.
Anders UlvenstamInstitution of Public Health and Clinical Medicine, Östersund, Umeå University, Umeå, Sweden.
Anna-Lotta IrevallInstitution of Public Health and Clinical Medicine, Östersund, Umeå University, Umeå, Sweden.
Lars SöderströmInstitution of Public Health and Clinical Medicine, Östersund, Umeå University, Umeå, Sweden.
Thomas MooeInstitution of Public Health and Clinical Medicine, Östersund, Umeå University, Umeå, Sweden.
Umeå University · SE

Funding

Region Jämtland Härjedalen JLL 939201
6 · The paper itself

Abstract

Progress in decreasing ischemic complications in acute coronary syndrome (ACS) has come at the expense of increased bleeding risk. We estimated the long-term, post-discharge incidence of serious bleeding, characterized bleeding type, and identified predictors of bleeding and its impact on mortality in an unselected cohort of patients with ACS. In this population-based study, we included 1379 patients identified with an ACS, 2010-2014. Serious bleeding was defined as intracranial hemorrhage (ICH), bleeding requiring hospital admission, or bleeding requiring transfusion or surgery. During a median 4.6-year follow-up, 85 patients had ≥ 1 serious bleed (cumulative incidence, 8.6%; 95% confidence interval (CI) 8.3-8.9). A subgroup of 557 patients, aged ≥ 75 years had a higher incidence (13.4%) than younger patients (6.0%). The most common bleeding site was gastrointestinal (51%), followed by ICH (27%). Sixteen percent had a recurrence. Risk factors for serious bleeding were age ≥ 75 years, lower baseline hemoglobin (Hb) value, previous hypertension or heart failure. Serious bleeding was associated with increased mortality. Bleeding after ACS was fairly frequent and the most common bleeding site was gastrointestinal. Older age, lower baseline Hb value, hypertension and heart failure predicted bleeding. Bleeding did independently predict mortality.

Indexed as

Acute Coronary SyndromeAgedCohort StudiesFemaleFollow-Up StudiesHemorrhageHumansIncidenceMaleMiddle AgedPatient Discharge

Identifiers

PMID34754030
PMCPMC8578330
OpenAlexW3214027144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.